BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai Q, Spoletini G, Bianco G, Graceffa D, Agnes S, Rossi M, Lerut J. SARS-CoV2 and immunosuppression: A double-edged sword. Transpl Infect Dis 2020;22:e13404. [PMID: 32639598 DOI: 10.1111/tid.13404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Martínez-Urbistondo M, Gutiérrez-Rojas Á, Andrés A, Gutiérrez I, Escudero G, García S, Gutiérrez A, Sánchez E, Herráiz J, De La Fuente S, Callejas A, De Mendoza C, Moreno-Torres V. Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients. J Clin Med 2021;10:3595. [PMID: 34441891 DOI: 10.3390/jcm10163595] [Reference Citation Analysis]
2 Villa L, Krüger T, Seikrit C, Mühlfeld AS, Kunter U, Werner C, Kleines M, Schulze-Hagen M, Dreher M, Kersten A, Marx N, Floege J, Rauen T, Braun GS. Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients. Medicine (Baltimore) 2021;100:e24893. [PMID: 33725847 DOI: 10.1097/MD.0000000000024893] [Reference Citation Analysis]
3 Spoletini G, Bianco G, Graceffa D, Lai Q. Transplantation during the COVID-19 pandemic: nothing noble is accomplished without danger. BMC Gastroenterol 2020;20:259. [PMID: 32762651 DOI: 10.1186/s12876-020-01401-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ertl HCJ. T Cell-Mediated Immune Responses to AAV and AAV Vectors. Front Immunol 2021;12:666666. [PMID: 33927727 DOI: 10.3389/fimmu.2021.666666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Chalklin CG, Koimtzis G, Khalid U, Carrington-Windo E, Elker D, Asderakis A. SARS-CoV-2 Infection Can Lead to an Increase in Tacrolimus Levels in Renal Transplant Patients: A Cohort Study. Transpl Int 2022;35:10127. [PMID: 35387396 DOI: 10.3389/ti.2022.10127] [Reference Citation Analysis]
6 Madhu D, Sharma S, Agarwal A, Saraya A. Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review. J Clin Transl Hepatol 2021;9:568-75. [PMID: 34447687 DOI: 10.14218/JCTH.2021.00001] [Reference Citation Analysis]
7 Briguglio M, Crespi T, Pino F, Mazzocchi M, Porta M, De Vecchi E, Banfi G, Perazzo P. Clinical Characteristics of Severe COVID-19 Patients Admitted to an Intensive Care Unit in Lombardy During the Italian Pandemic. Front Med (Lausanne) 2021;8:582896. [PMID: 33842494 DOI: 10.3389/fmed.2021.582896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 DeJarnette C, Meyer CJ, Jenner AR, Butts A, Peters T, Cheramie MN, Phelps GA, Vita NA, Loudon-Hossler VC, Lee RE, Palmer GE. Identification of Inhibitors of Fungal Fatty Acid Biosynthesis. ACS Infect Dis 2021. [PMID: 34786940 DOI: 10.1021/acsinfecdis.1c00404] [Reference Citation Analysis]
9 Thanou A, Sawalha AH. SARS-CoV-2 and Systemic Lupus Erythematosus. Curr Rheumatol Rep 2021;23:8. [PMID: 33511495 DOI: 10.1007/s11926-020-00973-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mathiasen VD, Oversoe SK, Ott P, Jensen-Fangel S, Leth S. Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression: A Case Report. Transplant Proc 2020;52:2703-6. [PMID: 33039144 DOI: 10.1016/j.transproceed.2020.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Haavik H, Niazi IK, Kumari N, Amjad I, Duehr J, Holt K. The Potential Mechanisms of High-Velocity, Low-Amplitude, Controlled Vertebral Thrusts on Neuroimmune Function: A Narrative Review. Medicina (Kaunas) 2021;57:536. [PMID: 34071880 DOI: 10.3390/medicina57060536] [Reference Citation Analysis]